Healthcare
Latest news, explainers and analysis on Healthcare. Tracking 11 stories on Arth Vani.
Connected in the graph
Latest on Healthcare
IPOTPG Files Confidential IPO Application for Malaysian Hospital Assets, Valued Around ₹66,000 Crore
Global private equity firm TPG has confidentially filed an application for an Initial Public Offering (IPO) of its hospital assets in Malaysia. The proposed IPO is reportedly valued at approximately $8 billion, which translates to about ₹66,000 crore, according to The Wall Street Journal.
BreakingCGHS Eases Rules: Dependent Sons, Brothers with Critical Illnesses Get Lifetime Benefits
The Central Government Health Scheme (CGHS) has relaxed its rules, allowing dependent sons and brothers suffering from critical or terminal illnesses to receive medical benefits for their entire lifetime. This change provides long-term financial relief for families managing severe health conditions.
Mahajan Imaging and Neuberg Diagnostics Form JV to Expand Pathology in North India
Diagnostic giants Mahajan Imaging and Neuberg Diagnostics have entered a strategic joint venture to scale pathology and genomics services across North India. The partnership focuses on early disease detection and integrated diagnostic infrastructure to capture a larger share of the organized healthcare market.
Diversification vs. Recovery: How Indian Investors Should Weigh Healthcare Stock Choices
Indian investors considering large healthcare stocks like Abbott and Thermo Fisher often face a dilemma: invest in a well-diversified company for steady growth or a company poised for significant recovery. The choice depends on individual risk appetite and investment goals.
IPOBreakingMolbio Diagnostics IPO: Price Band ₹768-₹807, Opens Aug 10
Molbio Diagnostics has announced its Initial Public Offering (IPO) with a price band set between ₹768 and ₹807 per share. The subscription period will be open from August 10 to August 12.
BreakingGovernment Considers National Safety Framework for Dental Implants
India's government is exploring a national regulatory framework for dental implants to address concerns over unregulated use and ensure patient safety. This initiative aims to standardize the manufacturing, sale, and clinical application of these medical devices across the country.
IPOBreakingManipal Health Eyes ₹8,000 Cr IPO for Expansion, Debt Repayment
Manipal Health Enterprises is planning an ₹8,000 crore Initial Public Offering (IPO) to fund its expansion and repay debt. While the company has shown strong revenue growth, investors are advised to watch for post-listing performance due to aggressive pricing concerns.
Gland Pharma Gets US FDA Nod for Generic Sugammadex Injection
Gland Pharma has received US FDA approval for its generic version of sugammadex injection, a drug used to reverse muscle relaxants during surgery. This approval marks a significant step for the company in the US market.
Healthcare ETFs: Key Factors Indian Investors Should Weigh for Comparison
This report explores the essential factors retail investors should consider when comparing healthcare Exchange Traded Funds (ETFs). Using examples like PINK and XLV, it outlines general comparison principles for making informed investment decisions, noting that specific data for these funds was not provided in the source material.
Pharma Stocks Shine: Why Indian Drugmakers Are Beating Market Volatility
Indian pharmaceutical stocks have emerged as a safe haven for investors, delivering strong returns despite global economic pressures. This growth is fueled by rising domestic medicine demand and a global shift in supply chains away from China.
Carlyle Prepares to Launch Healthcare Services IPO in India
Global private equity firm Carlyle is eyeing a public listing for its healthcare revenue cycle management platform. The company, formed by merging Knack RCM and EqualizeRCM, is currently in the process of selecting investment banks to manage the debut.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.